Data / Form D filings / Alterix Inc.
Alterix Inc.: Form D filing
Alterix Inc., a pharmaceuticals company in Beverly, MA, filed a Form D with the SEC in 2015. The latest, on September 1, 2015, reports $4.3 million sold of an offering with no set size to 2 investors.
Find out what Alterix Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 CUMMINGS CENTER, SUITE 463E, Beverly, MA, 01915
- Phone
- (978) 750-0900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1638851
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2015 | New notice | Indefinite | $4,250,000 | Indefinite | 2 | Aug 17, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Janice D. DiPietro, D.B.A. | Director | |
| Galen D. Grayson, M.D. | Director | |
| Harry G. McCoy, Pharm.D. | Director | |
| John J. Clark Jr. | Director | |
| Frank A. Manguso | Director | |
| Patrick T. Mooney, M.D. | Executive Officer, Director | |
| David R. Staskin, M.D. | Executive Officer, Director | |
| Frederic J. de Bure | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Aug 31, 2015 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alterix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.